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Introduction
Meiosis in mammalian oocytes is driven by changes in the 
activity of maturation-promoting factor (MPF). MPF activity is 
attributed entirely to the activity of the universal mitotic kinase, 
cdk1–cyclin B (Draetta et al., 1989; Labbe et al., 1989; Gautier 
et al., 1990). In mammals, oocytes are arrested in prophase of 
meiosis I with low levels of MPF (Hashimoto and Kishimoto, 
1986; Choi et al., 1991). An increase in MPF activity stimulates 
entry into M phase of meiosis I, the fi  rst sign of which is germinal 
vesicle (GV) breakdown (GVBD), which takes place  90 min 
after release from the follicle. Continued cyclin B synthesis and 
increasing levels of MPF drive the oocyte to metaphase of the 
fi  rst meiotic division (Tay et al., 2000; Ledan et al., 2001), 
which is followed by polar body extrusion 7–9 h after GVBD. 
After MI, the oocyte proceeds immediately to meiosis II, where 
it arrests with high levels of MPF activity that are stabilized by 
cytostatic factor (CSF; Masui and Markert, 1971; Hashimoto 
and Kishimoto, 1986; Kubiak et al., 1993; Tunquist and Maller, 
2003). The MI→MII transition is characterized by a transient 
decrease in MPF activity brought about by the destruction of 
cyclin B (Hashimoto and Kishimoto, 1986; Ledan et al., 2001; 
Herbert et al., 2003; Marangos and Carroll, 2004a). Cyclin deg-
radation is stimulated in meiosis and mitosis by the anaphase-
promoting complex (APC), an E3 ubiquitin ligase for which 
several mitotic proteins, including cyclin B, are substrates. The 
APC-catalyzed formation of a ubiquitin chain on cyclin B marks 
it for destruction by the 26S proteasome, and the inactivation of 
MPF rapidly follows (Glotzer et al., 1991; King et al., 1996; 
Fang et al., 1999; Zachariae and Nasmyth, 1999).
Regulation of cdk1 by cyclin availability requires that the 
APC is tightly regulated so as to destroy cyclin B (and its other 
substrates) in a timely manner (Peters, 2002). Not surprisingly, 
therefore, the APC is subject to a variety of regulatory mechanisms. 
APC activity requires one of two positive regulators, Cdc20 
and Cdh1, that are required for APC activity in mitosis and late 
mitosis/G1, respectively (Kramer et al., 1998; Lorca et al., 1998; 
Raff et al., 2002; Chang et al., 2004). It is also positively regulated 
by cdk1–cyclin B–dependent phosphorylation, thereby providing a 
feedback loop that ensures a rapid exit from metaphase (Felix et al., 
1990; Golan et al., 2002). Inactivation of the APC is mediated 
by several proteins that make up the spindle assembly checkpoint 
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(Li and Nicklas, 1995; Cleveland et al., 2003). The proteins 
MAD2 and BubR1 complex with Cdc20 to ensure that the APC 
remains inactive until all chromosomes are bioriented on the 
  spindle (Fang et al., 1998; Fang, 2002; Homer et al., 2005).
A more recently discovered APC inhibitor is early mitotic 
inhibitor 1 (Emi1; Reimann et al., 2001a,b; Reimann and Jackson, 
2002). Depletion of Emi1 from mammalian cells results in an 
S-phase arrest as a result of the failure to accumulate S-phase 
activators, including cyclin A. In cycling Xenopus laevis ex-
tracts, the depletion of Emi1 arrests the extract before entry into 
mitosis as a result of a failure to accumulate cyclin B (Reimann 
et al., 2001a; Hsu et al., 2002). In prometaphase, Polo-like 
kinase–dependent phosphorylation of Emi1 targets it for 
destruction through the Skp1–Cul1–F-box (SCF) E3 ubiquitin 
ligase pathway (Hansen et al., 2004; Moshe et al., 2004). The 
F-box protein βTrCP is responsible for recruiting Emi1 to its 
SCF partners (SCF–βTrCP), triggering Emi1 degradation 
(Guardavaccaro et al., 2003; Margottin-Goguet et al., 2003). 
The inactivation of Emi1 in prometaphase is necessary to allow 
APC
Cdc20 activation during mitosis, which is necessary to 
coordinate the destruction of securin and cyclin B.
Experiments conducted thus far address the role of Emi1 
in meiosis II but have not focused on a role in meiosis I 
(Reimann and Jackson, 2002; Ohsumi et al., 2004; Paronetto 
et al., 2004; Shoji et al., 2006). However, there is evidence to 
indicate that Emi1 may play a role during meiosis I. A recent 
study shows that APC
Cdh1 activity was found to be important for 
preventing the entry of prophase I–arrested mouse oocytes into 
the fi  rst meiotic division (Reis et al., 2006). This effect may be 
mediated by suppressing the levels of meiotic activators such as 
cyclin B1. This rather surprising fi  nding provides a new poten-
tial role for APC regulation by Emi1 in meiosis I.
In this study, we investigate the role of Emi1 in meiosis I 
using exogenous GFP-hEmi1 and by depleting Emi1 from pro-
phase I–arrested oocytes using morpholino (MO) oligonucleotides. 
We show that Emi1 is present in mouse oocytes and that its 
destruction is initiated immediately after GVBD. Microinjection 
of excess Emi1 accelerates entry into the fi  rst meiosis and 
arrests the oocyte at MI. The depletion of Emi1 delays entry 
into meiosis I and prevents normal MI spindle formation. 
Finally, we show that the effects of Emi1 depletion require 
Cdh1, thereby demonstrating that Emi1-dependent regulation 
of APC
Cdh1 is essential for regulating prophase I arrest and pro-
gression through meiosis I.
Results
Emi1 is expressed in mouse oocytes
We fi  rst examined whether Emi1 was expressed in mouse 
oocytes. RT-PCR of mRNA extracted from 15 GV-stage oocytes 
generated a product of the expected molecular weight (218 bp). 
Control samples lacking reverse transcriptase failed to generate 
a PCR product (Fig. 1 A). In situ hybridization analysis of 
mouse ovaries reveals the wide-spread expression of Emi1, with 
the highest signal being present in oocytes and granulosa cells 
(Fig. 1 B). Negative controls show no signal arising from 
  oocytes or granulosa cells (unpublished data). Western blotting 
analysis using an anti-Emi1 antibody revealed a band at the ex-
pected molecular mass of 49 kD (Fig. 1, C–F). To identify Emi1 
in our Western blotting experiments, we used an Emi1 MO to 
deplete the protein. Emi1 MO and control MO were injected 
into GV-stage oocytes. Injected oocytes were maintained in 
3-isobutyl-1-methylxanthine  (IBMX)–mediated prophase I arrest 
for 24 h before being subjected to analysis by Western blotting 
Figure 1.  Emi1 is expressed in GV-arrested 
oocytes. (A–C and E) RT-PCR (15 oocytes; A), 
in situ hybridization (B), and Western blotting 
(200 oocytes/embryos; C and E) show the 
presence of Emi1 at the mRNA and protein 
level in GV-stage oocytes. (C) To identify the 
band corresponding to Emi1 in our Western 
blotting experiments, we depleted Emi1 from 
mouse oocytes by the use of a morpholino 
(MO) oligonucleotide targeted against mEmi1. 
A 49-kD band can be identiﬁ  ed as Emi1 be-
cause it is present in oocytes injected with a 
control MO but absent from Emi1 MO–injected 
oocytes (three experiments). The loss of immuno-
reactivity corresponds to an 83% depletion 
of Emi1 in GV-stage oocytes injected with 
mEmi1 MO. (D) Further veriﬁ  cation of the band 
corresponding to Emi1 was provided by an an-
tigen block experiment in which the band is 
only present in the sample where the Gentaur 
Emi1 antibody is not neutralized by incubation 
with human Emi1 protein before blotting (two 
experiments). Arrow indicates Emi1. (E and F) 
One-cell embryos (E) and 3T3 cells (F) were 
  arrested in metaphase with nocodazole (two 
experiments). The immunoreactive Emi1 shows 
an expected decrease in metaphase. Samples of 
5 μg 3T3 cell lysates were used. Reprobing the 
blots with actin shows that loading is the same 
in the lanes examined. Pn, pronucleus stage.EMI1 CONTROLS PROPHASE ARREST IN MOUSE OOCYTES • MARANGOS ET AL. 67
(Fig. 1 C). Emi1 MO but not control MO resulted in the down-
regulation of a 49-kD Emi1 band to  17% of control levels 
(Fig. 1 C). The depletion of Emi1 appeared to be specifi  c, as 
several cross-reactive bands did not show any change, and rep-
robing the blot for actin revealed that loading was similar in the 
two lanes. Furthermore, using hEmi1 as an antigen block, we 
were able to eliminate the Emi1 band on the blot (Fig. 1 D). 
This Emi1 band was also present in interphase pronucleate-
stage embryos but was reduced in one-cell embryos arrested in 
mitosis using nocodazole (Fig. 1 E). This is consistent with the 
known cell cycle–dependent destruction of Emi1 in prometa-
phase (Reimann et al., 2001a; Margottin-Goguet et al., 2003). 
This was confi  rmed in 3T3 cells in the same conditions used for 
oocytes and embryos (Fig. 1 F).
The destruction of Emi1 occurs 
during oocyte maturation and is required 
for the MI→MII transition
The levels of Emi1 protein present during oocyte maturation 
were examined using Western analysis. At the GV stage, 
an immunoreactive protein was present. During maturation, the 
intensity of the band decreased to barely detectable levels in 
MI- and MII-stage oocytes (Fig. 2 A). This indicates that Emi1 
is destroyed between GVBD and MI. Emi1 destruction may be 
necessary during maturation to permit an increase in APC ac-
tivity and, thereby, the destruction of securin and cyclin B during 
the MI→MII transition. To test the requirement of Emi1 de-
struction, we used two independent approaches. First, we ex-
pressed GFP-hEmi1 during meiosis so as to maintain elevated 
levels of Emi1 during meiosis, and, second, we inhibited Emi1 
destruction using βTrCP∆F. βTrCP∆F is a dominant-negative 
form of βTrCP, which binds to substrates such as Emi1 but not 
to the SCF ligase (Margottin-Goguet et al., 2003). In both experi-
mental paradigms, the phenotype is the same: arrest at meiosis 
I with an intact spindle and condensed, aligned chromosomes 
(Fig. 2, B and C). Thus, Emi1 destruction is necessary during 
MI, presumably to allow the APC to become active once all 
other checkpoint requirements have been met.
Emi1 destruction is initiated immediately 
after GVBD and is SCF–𝗃TrCP dependent
The loss of Emi1 immunoreactivity between the GV stage and 
MI suggests that Emi1 stability changes during oocyte maturation. 
In mitotic cells, Emi1 destruction is initiated in prophase 
and requires phosphorylation by Polo-like kinase 1 (Hansen 
et al., 2004; Moshe et al., 2004). To relate the timing of Emi1 
destruction to meiotic progression, we asked whether Emi1 
stability changed around the time of GVBD as oocytes make the 
transition from prophase to M phase. Oocytes were coinjected 
with a 70-kD rhodamine-dextran to provide an accurate timing 
of GVBD and with complementary RNA (cRNA) for GFP-
hEmi1 to provide a measure of Emi1 stability. Imaging experi-
ments revealed that before GVBD, Emi1 was stable and showed 
only a minor decrease in fl  uorescence (Fig. 3 A). The onset of 
GVBD was marked by an increase in rhodamine fl  uorescence in 
the region of the GV, and, within 5 min, an increase in the de-
struction of GFP-hEmi1 was detectable (Fig. 3 A). The time 
course of destruction of endogenous Emi1 was investigated 
using Western analysis of oocytes at the GV stage after GVBD 
and progressively through meiosis I (3, 6, and 9 h after release 
from IBMX). The data show that Emi1 is high in GV-stage 
oocytes and is reduced by 3 h after release from meiotic arrest 
(Fig. 3 B). Together, these data show that GVBD is tightly cor-
related with and may initiate the onset of Emi1 destruction.
To verify that Emi1 was being destroyed in oocytes by the 
established SCF–βTrCP-dependent pathway, GFP-hEmi1 sta-
bility was monitored in oocytes coinjected with the dominant-
negative form of βTrCP (βTrCP∆F). The coinjection of 
βTrCP∆F resulted in a three- to fourfold decrease in the rate of 
Emi1 destruction after GVBD (Fig. 3, C and D).
Emi1 is sufﬁ  cient to accelerate entry 
into the ﬁ  rst meiosis
Because Emi1 is an APC inhibitor, it is likely to infl  uence the 
levels of cyclin, which may alter the timing of progression 
through meiosis I. In experiments described in Fig. 2, we ob-
served an apparent acceleration of GVBD in GFP-hEmi1–
  injected oocytes. This was confi  rmed by designing experiments 
in which GVBD was scored every 10–15 min in control and 
GFP-hEmi1–injected oocytes. GFP-hEmi1–injected oocytes 
underwent GVBD earlier than control GFP cRNA-injected 
  oocytes (Fig. 4 A). Thus, after release from IBMX, 50% of 
GFP-hEmi1–injected oocytes had undergone GVBD at 45 min 
compared with 60 min in the control. Maximal rates of GVBD 
were achieved at 60 min in GFP-hEmi1–injected oocytes com-
pared with 75 min in the controls (Fig. 4 A).
Figure 2.  Emi1 destruction is necessary for progression through meiosis I. 
(A) Western blot analysis (200 oocytes/lane) shows that Emi1 immuno-
reactivity decreases between the GV stage and metaphase I (MI; 6 h after 
release from prophase arrest) and remains at low levels in metaphase II 
(three experiments). (B and C) GV-stage oocytes were injected with GFP-
hEmi1 (three experiments) or βTrCP-∆F (two experiments) cRNA, and polar 
body (Pb1) emission was scored. Maintaining Emi1 through meiosis I in-
hibits polar body extrusion. Labeling of tubulin with immunoﬂ  uorescence 
showed that the GFP-hEmi1–injected oocytes were arrested at metaphase, 
as revealed by the presence of an intact MI spindle at the cortex (C, panel I) 
and aligned chromosomes (C, panel II; different oocyte than panel I). 
A similar phenotype is induced by βTrCP-∆F. The number of oocytes as-
sessed for each condition is given in parentheses. Error bars represent SD. 
*, P < 0.0001. Bars, 10 μm. JCB • VOLUME 176 • NUMBER 1 • 2007  68
We next examined whether the expression of GFP-hEmi1 
could override cAMP-mediated prophase arrest. Oocytes were 
incubated in 30 μM IBMX, which allows  10% of GFP cRNA-
injected oocytes to escape meiotic arrest during incubation for 
20 h (Fig. 4 B). In these conditions, the rate of GVBD after the 
injection of GFP-hEmi1 was increased to 70% (Fig. 4 B). These 
data show that Emi1 has a dramatic effect on entry into the fi  rst 
meiotic division, presumably as a result of its ability to inhibit 
the APC.
Next, we examined whether Emi1 regulates APC activity 
in GV-stage oocytes by monitoring the rate of destruction of the 
APC substrate cyclin B1–GFP in IBMX-arrested oocytes in-
jected with a cRNA for myc-hEmi1. The injected cyclin 
B1–GFP protein was degraded slowly in GV-stage oocytes, 
with  10% of the signal being depleted over 3 h (Fig. 4 C). In 
oocytes previously injected with myc-Emi1, the rate of cyclin 
B1–GFP destruction was attenuated such that only 3% of 
the cyclin B1–GFP was destroyed in the same period. These 
experiments show that the APC is active in prophase-arrested 
oocytes and that its inhibition by Emi1 is suffi  cient to accelerate 
the resumption of meiosis.
Depletion of Emi1 delays entry 
into the ﬁ  rst meiotic division
To understand the physiological role of Emi1 in meiosis I, we next 
examined the timing of GVBD in Emi1 MO–injected oocytes. 
Figure 3.  Emi1 destruction is initiated at GVBD 
and is regulated by SCF–𝗃TrCP. (A) Fluorescence 
measurements of rhodamine-dextran and GFP-
hEmi1 in the regions of interest (white circle) 
over the period of GVBD. The large increase in 
rhodamine ﬂ  uorescence in the GV area marks 
GVBD. This is rapidly followed by an increase 
in the destruction of GFP-hEm1 (three experi-
ments). (B) Endogenous Emi1 destruction early 
in meiosis I was determined by Western blot-
ting and was found to occur by 3 h from 
release from prophase arrest. Time values cor-
respond to time from the release from IBMX 
(150 oocytes; two experiments). (C) Records 
of GFP-hEmi1 in control oocytes and oocytes 
expressing  βTrCP-∆F. (D) GFP-hEmi1 levels 
are stabilized after GVBD by the presence 
of  βTrCP-∆F (two experiments). The number 
of oocytes is given in parentheses. Time at 
0 min corresponds to the release of GV-stage 
oocytes from IBMX. Error bars represent SD. 
*, P < 0.0001.
Figure 4.  Emi1 accelerates GVBD and stabilizes cyclin B in 
mouse oocytes. (A) Timing of GVBD in oocytes injected with 
GFP-hEmi1 cRNA 12–14 h before release from 200 μM 
IBMX (time 0). Control oocytes were injected with GFP cRNA 
and treated identically to GFP-hEmi1–containing oocytes. 
Note the acceleration of GVBD by GFP-hEmi1. Data are from 
four experiments. (B) Oocytes were injected with GFP-hEmi1 
or GFP (controls) and incubated for 24 h in 30 μM IBMX. 
GFP-hEmi1 overrides IBMX-mediated arrest. Data are from 
three experiments. (C) Representative traces showing the rate 
of cyclin B1–GFP destruction in control oocytes and in oocytes 
coinjected with cRNA for myc-hEmi1. Oocytes were main-
tained in 200 μM IBMX for the duration of the experiment. In 
the right panel, the rate of cyclin B1 destruction is quantiﬁ  ed. 
Data are from two experiments. The number of oocytes as-
sessed for each condition is given in parentheses. Error bars 
represent SD. *, P < 0.0001; **, P < 0.01. EMI1 CONTROLS PROPHASE ARREST IN MOUSE OOCYTES • MARANGOS ET AL. 69
As shown in Fig. 1 C, Emi1 MO–injected oocytes are depleted 
of  83% of the endogenous Emi1 after 24 h of culture. If Emi1-
dependent regulation of the APC plays a role in the timing 
of meiosis entry, the depletion of Emi1 would be expected to 
  increase APC activity and maintain meiotic arrest. The results in 
Fig. 5 A show that consistent with this hypothesis, the depletion 
of Emi1 delays GVBD such that 50% of control oocytes  undergo 
GVBD at 65 min after release from IBMX compared with 110 min 
in Emi1 MO–treated oocytes (Fig. 5 A). This delay was rescued 
by the coinjection of cRNA encoding GFP-hEmi1, suggesting 
that effects are specifi  c to the depletion of Emi1.
The depletion of Emi1 may prevent the accumulation of 
APC substrates such as cyclin B1. This would be expected to 
result in a delay in MPF activation. To test this possibility, we 
measured H1 kinase activity in Emi1 MO–injected oocytes 
(Fig. 5 B). H1 kinase activity in control oocytes increased 2.5-
fold in the fi  rst hour and fourfold over 3 h. Emi1 MO treatment 
delayed H1 kinase activity such that no increase was apparent 
after 1 h, reaching a maximum twofold increase at 2 h (Fig. 5 B). 
This increase was apparently suffi  cient to induce GVBD, but 
with much delayed timing.
To confi  rm that Emi1 MO caused cyclin B1 instability in 
GV-stage oocytes, we monitored the rate of cyclin B1–GFP 
  accumulation after microinjection with cyclin B1 cRNA in 
  oocytes injected with control and Emi1 MOs. Emi1 MO–injected 
oocytes accumulated cyclin B1–GFP at a rate three- to fourfold 
slower than oocytes injected with control MO (Fig. 5 C). The 
decrease in cyclin B1–GFP fl  uorescence was caused by destruc-
tion because nondestructible cyclin B1
∆90-GFP was accumu-
lated at a rate twofold greater than that of controls (Fig. 5 C). 
This further illustrates that cyclin B1–GFP is undergoing 
destruction in GV-stage oocytes.
Emi1 is necessary for spindle formation 
and progression through MI
Continued cyclin synthesis and increasing MPF activity are re-
quired for progression through MI (Tay et al., 2000; Ledan 
et al., 2001). The decrease in MPF activity described in Emi1-
depleted oocytes raised the possibility that Emi1 may be needed 
for the cyclin B accumulation necessary for progression through 
the fi  rst meiotic division. We tested this hypothesis by exam-
ining Emi1-depleted oocytes for normal MI spindle formation 
Figure 5.  Depletion of Emi1 leads to premature APC activation and subsequent delay in GVBD. (A) The timing of GVBD is delayed in oocytes depleted of 
Emi1 using Emi1 MO. Coinjection of GFP-hEmi1 with Emi1 MO reverses the delay. The experiment was repeated four times. (B) H1 kinase (MPF) and MBP 
kinase (MAPK) activities in control oocytes and Emi1-depleted oocytes. Representative of two independent experiments. (C) Representative traces (left) and 
quantiﬁ  cation (right) of the effect of Emi1 depletion on the accumulation of cyclin B1–GFP. Emi1-depleted oocytes have a much reduced ability to accumu-
late cyclin B1–GFP. Nondestructible cyclin B1
∆90-GFP accumulates at a rate ﬁ  ve- to sixfold more than cyclin B1–GFP, showing that the effects of Emi1 MO 
are caused by cyclin B1 stability rather than translation. Data were obtained from two experiments. Time 0 corresponds to 15 min after cRNA injection. 
The number of oocytes assessed for each condition is given in parentheses. Error bars represent SD. *, P < 0.0001. JCB • VOLUME 176 • NUMBER 1 • 2007  70
and the ability to extrude the fi  rst polar body. Emi1-depleted 
and control oocytes were matured and fi  xed, and their spindles 
and chromosomes were examined using confocal microscopy. 
Control MO–injected oocytes progress through MI and extrude 
the fi  rst polar body, so, for the purpose of comparison, an image 
of a control oocyte at MI is shown 7–8 h after release from 
IBMX (Fig. 6 A, I). In contrast to the normal spindles that form 
in controls, Emi1 MO–treated oocytes showed only the most 
rudimentary of spindle structures even after prolonged incuba-
tion for 12–24 h (Fig. 6, A and B). The extent of microtubule 
polymerization was limited and was often restricted to two 
small spindle poles (Fig. 6, A and B). Staining of chromatin in 
the Emi1-depleted oocytes revealed that the chromatin formed 
a condensed clump associated with the putative spindle structure. 
Individual chromosomes could not be resolved (Fig. 6 A). This 
phenotype is also observed after the expression of βTrCP in 
  oocytes, which was used as an indirect way to verify that the Emi1 
MO effect is specifi  c to Emi1 depletion (Fig. 6 C). This effect 
was further confi  rmed to be specifi  c for the effects of Emi1 
  depletion because it was partially reversed using GFP-hEmi1 
(Fig. 6, A and B). Coinjection of GFP-hEmi1 cRNA and Emi1 MO 
resulted in the presence of spindlelike structures and an in-
creased microtubular area after release from cAMP-mediated 
arrest compared with Emi1-depleted oocytes (Fig. 6, A and B). 
We confi  rmed in a separate series of experiments that Emi1 MO 
results in inhibition of the MI→MII transition (Fig. 6 C). This 
effect was not reversed by exogenous GFP-hEmi1, but this 
is not surprising given that excess Emi1 also causes arrest at 
MI (Fig. 2 B).
The effects of Emi1 depletion 
on meiosis I are mediated by APC
Cdh1
To test the hypothesis that the effects of Emi1 on GVBD and 
polar body extrusion are mediated by APC
Cdh1, we coinjected 
Emi1 MO and Cdh1 MO. If Cdh1 is the downstream effector of 
Emi1, the depletion of Emi1 would be expected to be without 
effect in Cdh1-depleted oocytes. Oocytes were injected with 
control, Emi1, or a previously characterized Cdh1 MO (Reis 
et al., 2006) or were coinjected with Emi1 and Cdh1 MO. The 
oocytes were then incubated in 30 μM IBMX, and GVBD and 
polar body extrusion were examined at 24 and 48 h.
As expected from previous experiments, the control and 
Emi1 MO–injected oocytes remained arrested at the GV stage 
throughout the 48-h incubation (Fig. 7 A). Consistent with a 
previous study (Reis et al., 2006), oocytes injected with Cdh1 
MO alone underwent GVBD such that  40 and 80% of oocytes 
underwent GVBD at 24 and 48 h, respectively (Fig. 7 A). 
Oocytes coinjected with Emi1 MO and Cdh1 MO underwent 
GVBD at rates similar to those receiving Cdh1 MO alone. This 
indicates that Emi1 acts in the same pathway as Cdh1 in regu-
lating meiotic arrest.
It was noted that most oocytes coinjected with Emi1 MO 
and Cdh1 MO progressed beyond GVBD and went on to ex-
trude the fi  rst polar body by the 48-h time point (Fig. 7 B). This 
is consistent with the observation that several of these oocytes 
displayed apparently normal MI spindles with aligned chromo-
somes at the 24-h time point (unpublished data). To confi  rm 
that controls progress to MI and that oocytes injected with 
Emi1 MO alone display prometaphase arrest, as shown in Fig. 6, 
a proportion of these oocytes was released from IBMX after 
24 h and scored for polar body extrusion at 48 h (Fig. 7 B). 
The results confi   rm that Emi1MO–injected oocytes arrest 
in prometaphase and that this arrest is reversed in the absence 
of Cdh1.
Figure 6.  Emi1 is important for spindle formation. (A) Control MO–
injected oocytes were released from IBMX and ﬁ   xed for immunocyto-
chemistry 7 h later, at the time when a fully developed spindle is formed 
(panel I), and chromosomes are aligned at the metaphase plate (panel IV). 
Emi1 MO–injected oocytes were ﬁ  xed 16–18 h after release from IBMX, 
by which time they were arrested (C). These oocytes show only the most 
rudimentary of spindle structures (panel II), whereas their chromosomes 
decondensed, forming clumps of chromatin (panel V). Coinjection of 
Emi1 MO and GFP-hEmi1 cRNA partially reverses the MO effect (panels 
III and VI). Bars, 10 μm. (B) The extent of rescue was determined by mea-
suring the microtubular area of the oocytes. Microtubule polymerization 
was three to four times stronger in GFP-hEmi1 + Emi1 MO–injected 
  oocytes than in oocytes injected with Emi1 MO alone (oocytes from both 
groups were ﬁ   xed and analyzed 16–18 h after release from IBMX; 
two experiments). (C) The absence of a normal spindle leads to the inhibi-
tion of polar body (Pb1) extrusion in Emi1 MO–injected oocytes (ﬁ  ve 
  experiments). Inhibition is also observed in oocytes coinjected with Emi1 
MO and GFP-hEmi1 cRNA because the MO phenotype is not totally re-
covered in these oocytes (three experiments). βTrCP cRNA expression in 
oocytes mimics the Emi1 MO effect, causing the inhibition of polar body 
extrusion (two experiments). The number of oocytes assessed for each 
condition is given in parentheses. Error bars represent SD. *, P < 0.0001; 
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Discussion
Emi1 is a relatively new player in the family of cell cycle pro-
teins that have a critical role in regulating the APC. It is known 
to restrain APC activity so as to allow the accumulation of 
  cyclin A and cyclin B in S and G2/M phases of the mitotic cell 
  cycle (Reimann et al., 2001a; Hsu et al., 2002). In this study, we 
describe the fi  rst defi  nitive evidence of a role for Emi1 acting 
via APC
Cdh1 in regulating the timing of entry into meiosis I and 
progression through the fi  rst meiotic division.
Emi1 in meiosis I: balancing prophase I 
arrest through APC
Cdh1
The importance of Emi1 in balancing meiotic arrest at prophase I 
is shown by the opposing effects of exogenous Emi1 and the 
  depletion of Emi1 on the timing of GVBD. Entry into the fi  rst 
meiotic division is delayed or inhibited by the depletion of Emi1 
and is accelerated by excess Emi1. The APC is apparently the 
target of Emi1 in mediating entry into meiosis I because exoge-
nous Emi1 leads to an increase in the stability of the APC sub-
strate cyclin B1, whereas Emi1 depletion leads to cyclin B1–GFP 
instability. This increase in cyclin instability likely explains the 
much-attenuated increase in MPF activity during the fi  rst 3 h of 
the meiotic progression of Emi1-depleted oocytes. The recent 
observation that APC
Cdh1 is necessary for maintaining prophase I 
arrest in mouse oocytes (Reis et al., 2006) provides a strong 
lead as to the target of Emi1 for its role in regulating entry into 
meiosis I. Our results show that Emi1 MO is without effect in 
oocytes that are codepleted of Cdh1, indicating that the Emi1-
dependent inhibition of APC
Cdh1 is important in the control of 
entry into meiosis I. Thus, prophase I arrest is critically poised 
by the competing actions of APC
Cdh1 and Emi1. The physiol-
ogical regulation of Emi1-APC
Cdh1 that allows for a timely initi-
ation of meiotic maturation is a topic for future investigation.
Our observations may have wider implications for the role 
of Emi1 in the mitotic cell cycle. In mammalian somatic cells, 
Emi1 has been shown to inhibit APC
Cdh1 to allow the accumula-
tion of S-phase regulators, including cyclin A (Hsu et al., 2002). 
In cycling Xenopus extracts, the depletion of Emi1 leads to a 
failure of nuclei to enter metaphase, an effect attributed to the 
unbridled activity of APC
Cdc20 and a failure to accumulate cyclin B 
(Reimann et al., 2001a). The mouse oocyte has provided an 
  opportune model system in which the cell cycle is arrested at 
the G2→M transition. As a result, the effects of Emi1 depletion 
at the G2→M transition have been elucidated using highly spe-
cifi  c MO-based technology in which results can be interpreted 
independently of the effects of Emi1 on S phase. Indeed, this 
role in prophase I arrest in mammalian meiosis is entirely con-
sistent with the effects of the Drosophila melanogaster Emi1 
homologue Rca1, which, when mutated, results in G2 arrest 
(Grosskortenhaus and Sprenger, 2002). It will be important to 
determine whether entry into mitosis is controlled by Emi1-
APC
Cdh1 as it is at entry into meiosis I.
Recent studies have investigated the role of Emi1 in oocyte 
maturation (Paronetto et al., 2004; Shoji et al., 2006), but a role 
for Emi1 in entry into the fi  rst meiotic division has not been 
  revealed. This is likely a result of the fact that Emi1 was consid-
ered to be an excellent candidate for CSF and that the fi  rst ex-
periments targeted MII arrest (Paronetto et al., 2004; Shoji 
et al., 2006). In experiments on MII oocytes, we found that 
exogenous Emi1 delayed egg activation but that depletion only 
sensitized eggs to activation rather than caused egg activation 
(unpublished data). Furthermore, we have shown by Western 
analysis that the level of Emi1 protein decreases as oocytes 
  enter the fi  rst meiotic division. This is inconsistent with a role 
in MII arrest but entirely in line with a role in S phase and 
  prophase (Reimann et al., 2001a; Margottin-Goguet et al., 2003). 
In Xenopus oocytes, an Emi1 antibody inhibits GVBD (Tung 
and Jackson, 2005), but these authors raised concerns about 
cross-reactivity of the antibody with additional Emi1-related 
proteins, resulting in some uncertainty as to which Emi1 ortho-
logue was responsible. Assuming Emi1 was indeed the target in 
Xenopus oocytes, this study, together with the present data, sug-
gests a conserved role amongst vertebrates for Emi1 in regulating 
prophase I arrest.
Emi1 is required for formation 
of the MI spindle
Depletion of Emi1 from GV-stage oocytes delays GVBD, but 
a more dramatic effect is seen further downstream, where it 
Figure 7.  The effects of Emi1 in meiosis I are mediated by APC
Cdh1. (A and B) 
Emi1 depletion has no effect on GVBD in Cdh1-depleted oocytes (A), 
and depletion of Cdh1 reverses the effects of Emi1 MO on polar body 
(Pb1) extrusion (B). GV-stage oocytes were injected with control MO, Emi1 
MO, or Cdh1 MO or were coinjected with Emi1 MO and Cdh1 MO. 
Oocytes were incubated in medium containing 30 μM IBMX, and the rate of 
GVBD and polar body extrusion was recorded 24 and 48 h after injection. 
(B, left) At 24 h after injection, a proportion of the control MO and Emi1 
MO–injected oocytes were released from IBMX to conﬁ  rm that the Emi1 
MO was functioning to inhibit polar body extrusion as described in Fig. 6. 
(A) Emi1 MO does not maintain prophase I arrest in oocytes coinjected 
with Cdh1 MO. (B) Similarly, the early prometaphase arrest and resultant 
inhibition of polar body extrusion induced by Emi1 MO was reversed by 
the codepletion of Cdh1. The graph shows the proportion of GVBD-stage 
oocytes that extruded the ﬁ  rst polar body at 24 and 48 h after injection. 
The number of oocytes assessed for each condition is given in parentheses. 
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prevents formation of the MI spindle. As a result, extrusion of the 
fi  rst polar body does not take place. The small or absent spin-
dles and partially condensed chromatin is consistent with an 
arrest early in prometaphase I. We examined the localization of 
Mad2 using immunofl  uorescence in these arrested oocytes and 
found that Mad2 was surrounding the chromatin but was not 
localized to kinetochores (unpublished data), which is consis-
tent with an early prometaphase arrest (Wassmann et al., 2003). 
A likely explanation for the arrest at this stage is the failure 
of Emi1-depleted oocytes to accumulate cyclin B1, resulting 
in the muted (threefold) activation of MPF compared with 
  controls. It is already established that an increase in MPF activa-
tion driven by the continued synthesis of cyclin B1 is necessary 
for spindle formation and progression through MI (Polanski 
et al., 1998; Ledan et al., 2001; Marangos and Carroll, 2004b; 
Brunet and Maro, 2005). Presumably, the increased APC activ-
ity in the absence of Emi1 is suffi  cient to prevent MPF from 
reaching the critical levels required for spindle formation. This 
conclusion is further supported by the fi  nding that the spindle 
defect and inhibition of polar body extrusion are reversed in 
Emi1- and Cdh1-depleted oocytes. In addition to the effects on 
prophase I arrest, the suppression of APC
Cdh1 by Emi1 is clearly 
necessary for progression from prometaphase to metaphase of 
meiosis I.
In previous studies in mouse oocytes, the evidence for a 
role of Emi1 in meiosis I is contradictory (Paronetto et al., 2004; 
Shoji et al., 2006). These differences may be caused by prob-
lems with specifi  city and validation of the siRNA approaches 
(Shoji et al., 2006). In both cases, the studies were focused on 
a role in metaphase II. As such, the siRNA was injected just be-
fore release from meiotic arrest and would not have provided 
suffi  cient time to deplete the levels of Emi1 protein. In the pres-
ent study, we found it necessary to inject Emi1 MO 20–24 h be-
fore release from IBMX to achieve a >80% reduction in protein 
and a consistent phenotype. The partial reversal of the spindle 
defect using cRNA for Emi1 and the requirement of Cdh1 to in-
duce the phenotype are important controls pointing to the speci-
fi  city of the MO approach used in this study.
Emi1 destruction is necessary 
for the MI→MII transition
The requirement for Emi1 to be destroyed is shown by the 
injection of excess Emi1, which results in a strong block at 
MI with an apparently normal MI spindle. This phenotype is 
mimicked by the injection of βTrCP∆F, which inhibits the 
  destruction of SCF substrates, including Emi1 (Guardavaccaro 
et al., 2003; Margottin-Goguet et al., 2003; and this study). 
  Persistent or elevated levels of Emi1 during meiosis I most 
likely lead to an inhibition of the APC (probably APC
Cdc20) 
with the result that the spindle develops normally but cannot 
proceed further in the absence of APC
Cdc20-dependent cyclin B 
destruction. This requirement for APC activity is in agreement 
with the fi   nding that APC-dependent securin destruction is 
  necessary for homologue disjunction at MI in mouse oocytes 
(Herbert et al., 2003; Terret et al., 2003), although APC activity 
is apparently unnecessary for the MI→MII transition in Xenopus 
(Peter et al., 2001).
Our data show that Emi1 is largely destroyed between 
the GV and MI stages. Precise timing of the onset of Emi1 
destruction was investigated using GFP-hEmi1. These experi-
ments revealed that Emi1 destruction starts within 5–10 min 
of the GV becoming permeable to large molecular weight 
dextran molecules. The signifi  cance of the timing relative to 
GVBD may be coincidence because GVBD rapidly follows 
MPF activation, but it may indicate a role for the necessity of 
nuclear factors in initiating Emi1 destruction. βTrCP1 is a nu-
clear protein, whereas its homologue βTrCP2 is cytoplasmic 
(Davis et al., 2002). In somatic cells, it is thought that Emi1 
is bound by βTrCP1/βTrCP2 heterodimers before being ubiq-
uitinated by the SCF ligase (Guardavaccaro et al., 2003). This 
unusual feature of Emi1 as a βTrCP substrate may provide a 
fail-safe mechanism to prevent the premature destruction of 
Emi1 before MPF is activated suffi  ciently to induce nuclear 
envelope breakdown.
From Emi1 to Emi2: cyclin B stability 
during oocyte maturation
Regulation of cyclin stability is important for arresting the 
meiotic cell cycle at two stages. First, this is important in pro-
phase arrest, where the Emi1-dependent inhibition of APC
Cdh1 
increases cyclin B accumulation and controls entry into and 
progression through meiosis I. Emi1 destruction is stimulated 
after GVBD, marking the end of its main role in meiosis I. 
Arrest at metaphase II has been recently attributed to the Emi1 
orthologue Emi2 (Liu and Maller, 2005; Rauh et al., 2005; 
Tung et al., 2005; Hansen et al., 2006; Madgwick et al., 2006; 
Shoji et al., 2006). Thus, Emi1 plays an important role in tim-
ing of the early stages of meiotic maturation before handing 
over to spindle assembly checkpoint proteins in prometaphase 
I and fi  nally to Emi2 for controlling cyclin stability and arrest 
at MII (Fig. 8). 
Figure 8.  Regulation of the APC in meiosis. Low levels of APC activity 
are partly responsible for prophase I arrest. After release from the arrest 
and during the early stages of oocyte maturation, Emi1 ensures that 
APC activity is maintained at low levels, allowing cyclin B accumulation 
and MPF activation. After Emi1 destruction, this role is passed to spindle 
assembly checkpoint proteins such as MAD2 and BUBR1. During the 
MI→MII transition, cyclin B and securin destruction depend on APC 
  activation, which is provided by the silencing of the spindle assem-
bly  checkpoint. The expression of Emi2 during extrusion of the ﬁ  rst 
polar body will lead to APC inhibition and CSF arrest in metaphase II, 
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Materials and methods
Oocyte and embryo collection
GV-stage oocytes were retrieved from the ovaries of 21–24-d-old female 
MF1 mice 48 h after the administration of 7 IU of pregnant male serum go-
nadotrophin (PMSG; Intervet) by intraperitoneal injection. Ovaries were 
released into warmed M2 (Sigma-Aldrich) supplemented with 200 μM 
IBMX (Sigma-Aldrich) to prevent GVBD and were maintained at 37°C. For 
oocyte maturation experiments, GV-stage oocytes were washed three times 
and transferred to M16 at 37°C in an atmosphere of 5% CO2 in air. To re-
cover mature (MII) oocytes, human chorionic gonadotrophin (hCG;   Intervet) 
was administered 48–54 h after PMSG. Oviducts were removed 14–16 h 
after hCG. Cumulus masses were released into M2, and cumulus cells 
were removed by a brief incubation in M2 containing 300 μg/ml 
hyalauronidase (embryo-tested grade; Sigma-Aldrich). For the recovery of 
pronucleate embryos, female mice were mated with males at the time of 
hCG administration. The embryos were recovered from the oviduct in 
Hepes-buffered KSOM (Lawitts and Biggers, 1993) 27–28 h after hCG 
and mating. Embryos that were not immediately used were transferred to 
KSOM at 37°C in an atmosphere of 5% CO2 in air.
Microinjection
Oocytes were pressure injected using a micropipette and Narishige ma-
nipulators mounted on an inverted microscope (DM IRB; Leica). Oocytes 
were placed in a drop of M2 containing IBMX covered with mineral oil to 
prevent evaporation. Cells were immobilized with a holding pipette while 
the injection pipette was pushed through the zona pellucida until making 
contact with the oocyte plasma membrane. A brief overcompensation of 
negative capacitance caused the pipette tip to penetrate the cell. Micro-
injection was performed using a ﬁ  xed pressure pulse through a picopump 
(World Precision Instruments). Injection volumes were estimated at 2–5% of 
total cell volume by cytoplasmic displacement. The oocyte volume is  250 pl. 
After microinjection, the oocytes were removed in fresh drops of M2 + 
IBMX under oil and allowed to recover for a few minutes before any 
further manipulation.
Constructs and MO oligonucleotides
Human Emi1 was cloned into pCS2 + myc5 as described previously 
(Reimann et al., 2001a) and pCS2-eGFP-c1 (CLONTECH Laboratories, Inc.). 
pCS2-GFP was a gift from M.W. Klymkowsky (Colorado University, Boulder, 
CO). βTrCP and βTrCP∆F were cloned in pCS2 + HA (Margottin-Goguet 
et al., 2003). pMDL2–cyclin B1–GFP and pMDL2–cyclin B1
∆90-GFP were 
gifts from M. Herbert (University of Newcastle, Newcastle, United Kingdom; 
Herbert et al., 2003). cRNAs encoding each of these constructs were 
made in vitro using the mMESSAGE mMACHINE kit (Ambion). The cRNAs 
were polyadenylated, puriﬁ  ed, and dissolved in nuclease-free water to a 
concentration of  1 μg/μl before microinjection into GV-stage oocytes. 
For Emi1 knockdown in mouse oocytes, mEmi1 MO 5′-C  G  G  G  A  C  A  A  G  A-
A  A  G  A  C  A  A  T  G  T  T  A  C  T  T  -3′ (Gene Tools, LLC) was used at a concentration of 
1.5 mM. For Cdh1 knockdown, we used an already characterized cdh1 
MO (5′-C  C  T  T  C  G  C  T  C  A  T  A  G  T  C  C  T  G  G  T  C  C  A  T  G  -3′; Reis et al., 2006). To 
control for possible nonspeciﬁ  c effects of the MOs, a control MO was also 
used (5′-C  C  T  C  T  T  A  C  C  T  C  A  T  T  A  C  A  A  T  T  T  A  T  A  -3′).
RT-PCR
15 GV-stage oocytes were collected in 9 μl of nuclease-free water. After in-
cubation with 2 U DNase I at 37°C for 30 min, the samples were subjected 
to oligonucleotide (dT)-primed ﬁ  rst-strand cDNA synthesis in 20 μl by using 
the RETROscript kit (Ambion). The entire reaction was then used for PCR 
ampliﬁ   cation with Deep Vent DNA polymerase (New England Biolabs, 
Inc.) for 35 cycles. The primers used for amplifying a 218-bp-long mouse 
Emi1 sequence were 5′-G  T  G  G  A  G  G  T  G  G  C  A  A  A  G  A  C  A  T  T  -3′ and 5′-G  G  C  A-
A  A  G  G  A  C  C  C  A  C  T  T  T  A  C  -3′. The reaction was accompanied by a negative 
(minus RT enzyme) control, and the experiment was repeated three times.
In situ hybridization
Ovaries of PMSG-primed mice were ﬁ  xed in 4% PFA for 6 h followed by 
  incubation in 0.5 M sucrose in PBS overnight at 4°C. The ovaries were 
  embedded in optimal cutting temperature (Tissue-Tek), sectioned at 10 μm, 
and mounted on Superfrost slides (Fisher Scientiﬁ  c). The mouse Emi1 cDNA 
was subcloned into the pGEM3zf vector, linearized, and transcribed to syn-
thesize 
35S-labeled RNA probes. Hybridization mixtures with antisense and 
sense RNA probes were added to the slide and incubated overnight at 
50°C. Post hybridization washes consisted of RNaseA treatment and de-
creasing concentrations of SSC washes. Hybridized slides were then dehy-
drated and dried. Slides were dipped into NTB2 emulsion (Kodak), exposed 
for 2 d, developed photographically, and counterstained with Gill’s hema-
toxylin and eosin Y (0.5% wt/vol in ethanol). After counterstaining, tissues 
were cleared with xylene, mounted with Permount, visualized, and photo-
graphed with a camera (AxioCam; Carl Zeiss MicroImaging, Inc.).
Cell culture
3T3 cells were grown in DME supplemented with 10% FBS (Invitrogen). 
DMSO or 10 μM nocodazole/DMSO was added in subconﬂ  uent mono-
layers that were harvested 48 h later, lysed (50 mM Hepes, pH 7.5, 
75 mM NaCl, 10 mM glycerophosphate, 2 mM EGTA, 15 mM MgCl2, 
0.1 mM sodium orthovanadate, 1 mM DTT, 0.5% Triton X-100, and protease 
inhibitor cocktail [Sigma-Aldrich]), and incubated for 10 min on ice. Lysates 
corresponding to interphase (DMSO) or mitosis (nocodazole/DMSO) were 
centrifuged for 10 min at 10,000 g and 4°C. Protein concentration was 
determined using a protein assay kit (Bio-Rad Laboratories) according to 
the manufacturer’s instructions. 5 μg of lysate was loaded onto gels for 
Western blotting.
Western blotting
Oocytes (200 oocytes/sample) were washed in PBS/polyvinyl alcohol 
(PVA) and frozen in SDS sample buffer (Laemmli, 1970). Proteins were 
separated on 4–12% NuPAGE gels (Invitrogen) and transferred to poly-
vinylidene ﬂ  uoride Immobilon-P membranes (Millipore) using the XL II Blot 
Module (Invitrogen). The membranes were saturated with 5% nonfat dry 
milk in PBS containing 0.1% Tween 20 for 1 h at room temperature and 
were incubated with the primary antibodies overnight at 4°C. Three anti-
bodies were used for Western blot analysis of Emi1. 1 μg/ml rabbit poly-
clonal (Gentaur), a mouse monoclonal (Zymed Laboratories), and 1 μg/ml 
of an afﬁ  nity-puriﬁ   ed rabbit polyclonal antibody were raised against a 
bacterially produced myelin basic protein (MBP)−mEmi1 fusion protein. 
Rabbit polyclonal antibodies were afﬁ  nity puriﬁ  ed with mEmi1 fused to 
GST. All antibodies provide similar results. For clarity, we have presented 
data obtained using the Gentaur antibody. Antigen block was performed 
using the Gentaur antibody by preincubation for 1 h at room temperature 
with a threefold molar excess of human Emi1-MBP. For the detection of 
actin, we used 1 μg/ml of a mouse monoclonal antiactin antibody   (Chemicon). 
Secondary IgGs conjugated to 0.05 μM HRP (goat anti–rabbit IgG or 
mouse IgG; Sigma-Aldrich) were incubated with the membranes for 30 min 
at room temperature. Immunostained bands were detected by chemilu-
minescence (Pierce Chemical Co.).
Kinase assays
CDK1–cyclin B activity and MAPK activity were measured by their ability 
to phosphorylate histone H1 and MBP in vitro (H1 and MBP kinase assay), 
respectively, as previously described in detail (Marangos et al., 2003). 
Eight oocytes in 2 μl M2 were transferred in 3 μl of storing solution and 
immediately frozen on dry ice. The samples were diluted twice by the ad-
dition of concentrated kinase buffer (Marangos et al., 2003). The samples 
were then incubated at 37°C for 30 min and were analyzed by SDS-PAGE 
(as for Western blotting) followed by autoradiography. The autoradio-
graphs were imaged using the phosphorimager system (Bas-100; Fuji) and 
analyzed with TINA 2.0 software.
Puriﬁ  ed proteins
A baculovirus-based expression system was used to obtain recombinant 
human cyclin B1–GFP at a concentration of 2 mg/ml as described previ-
ously (Marangos and Carroll, 2004a). Sf9 insect cells infected with the 
baculovirus encoding His(6)
− cyclin B1–GFP were a gift from J. Pines (Gurdon 
Institute, University of Cambridge, Cambridge, United Kingdom).
Immunoﬂ  uorescence
Oocytes were ﬁ  xed in freshly prepared 4% PFA (in PBS, pH 7.4, 1 mg/ml 
PVA) for 20 min, washed in PBS/PVA, and permeabilized in 0.1% Triton X-
100 for 15 min. The cells were then incubated in blocking buffer (PBS, 3% 
BSA, and 10% normal goat serum) for 2 h at RT and in 5 μg/ml of a mouse 
anti–α-tubulin antibody (Abcam) in blocking buffer at 4°C overnight. 
The cells were incubated with 5 μg/ml of an AlexaFluor555-conjugated 
goat polyclonal anti–mouse IgG secondary antibody (Invitrogen) for 2 h 
at RT followed by incubation with 2 μM Hoechst 33342 to label the 
DNA. The immunostaining was visualized using a confocal microscope 
(LSM510 META; Carl Zeiss MicroImaging, Inc.). To ensure that compari-
sons of   immunoﬂ  uorescence could be made between treatment groups or 
developmental stages, the different samples were scanned and viewed 
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Imaging
For conventional microscopy, oocytes were placed in a drop of M2 me-
dium under oil in a chamber and placed on a microscope (Axiovert; Carl 
Zeiss MicroImaging, Inc.). Cyclin B1–GFP and GFP-hEmi1 were imaged 
using a FITC ﬁ  lter set (450–490-nm excitation band-pass ﬁ  lter, 510-nm di-
chroic mirror, and 505–520-nm band-pass ﬁ  lter for emission). Fluorescence 
was collected through a 20× NA 0.75 objective. For simultaneous imag-
ing of GFP and rhodamine-dextran, the ﬂ  uorophores were excited through 
a monochromator (Oolychrome II; Till Photonics), which was used to select 
excitation wavelengths of 488 and 550 nm. A triple band-pass (DAPI/
FITC/TRITC) dichroic mirror was used, and emitted ﬂ  uorescence was col-
lected through a 450–490-nm band-pass ﬁ  lter for GFP and a 600-nm-long 
pass ﬁ  lter for rhodamine. The emitted light from all of the ﬂ  uorochromes 
was collected using a cooled CCD camera (MicroMax; Princeton Scientiﬁ  c 
Instruments). In all imaging experiments using conventional microscopy, 
data were collected and analyzed using Metaﬂ  uor and MetaMorph software 
(Universal Imaging Corp.).
A confocal microscope (LSM510; Carl Zeiss MicroImaging, Inc.) 
was used for the monitoring of spindles and chromosomes in the immuno-
localization experiments. A 40× NA 1.3 oil immersion lens (Carl Zeiss 
  MicroImaging, Inc.) was used. Excitation of AlexaFluor555 was provided by 
the 543-nm laser line of a helion-neon laser, with the laser power set at 1% 
of maximum. Fluorescence was collected using a 560–615-nm band-pass 
emission ﬁ  lter. For imaging Hoechst, confocal images were   obtained by 
exciting with the 351-nm laser line of a UV laser, and emission was col-
lected through a 435–485-nm band-pass ﬁ  lter. For all confocal imaging ex-
periments, a pinhole of 2.22 Airy U was used, giving a calculated optical 
slice of 3.5 μm. The images were analyzed using MetaMorph software.
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